Table 3.
Gene expression profile of AFSCs
| ||||
Author, year (Ref) | Markers | Antigen or CD | First trimester | Second and third trimester |
Oct4 | + + | |||
Nanog | + | |||
Sox2 | + | |||
SSEA4 | + + | |||
c-Myc | + + | |||
Tra-1-60 | + | |||
SSEA3 | + | |||
Tra-1-81 | + | |||
ALPL | + | |||
Loukogeorgakis et al. , 2017 | Stem cell | Klf4 | + | |
Cananzi et al. , 2009 | CD29 | + + | ||
Guillot et al. , 2007 | CD44 | + + | ||
Baghaban Eslaminejad et al. , 2012 (59-62) | CD73 | + + | ||
CD90 | + + | |||
CD105 | + + | |||
CD166 | + + | |||
Mesenchymal | CD146 | + | ||
CD45 | ||||
CD34 | ||||
CD31 | ||||
Hematopoietic | CD14 | |||
HLA class I | ||||
MHC | HLA class II | |||
AFSCs: Amniotic fluid stem cells, CD: Cluster of differentiation, Oct4: Octamer-binding transcription factor 4, Nanog: Homeobox transcription factor nanog, Sox2: Sex determining region Y-box 2, SSEA4: Stage-specific embryonic antigen-4, c-Myc: A family of regulator genes and proto-oncogenes that code for transcription factors, Tra-1-60: A cell surface antigen, expressed along with SSEA-3, SSEA-4 and TRA-1-81 in human embryonic stem cells, SSEA3: Stage-specific embryonic antigen 3, Tra-1-81: A cell surface antigen expressed along with SSEA-3, SSEA-4 and TRA-1-60, ALPL: Provides instructions for making an enzyme called tissue-nonspecific alkaline phosphatase, Klf4: Kruppel like factor 4, MHC: Major histocompatibility complex, HLA: Human leucocyte antigen |